Frontiers in Pharmacology (Feb 2022)

Effect of 0.01% Atropine on Accommodation in Myopic Teenagers

  • Huixia Li,
  • Liying Zhang,
  • Hong Tian,
  • Song Zhang,
  • Xueyan Zhang,
  • Han Zhang,
  • Yujing Chen,
  • Wenping Qi,
  • Xiaoying Wu,
  • Hongmei Jiang,
  • Hailong Yang,
  • Yajun Yang,
  • Lei Liu,
  • Lei Liu,
  • Guisen Zhang

DOI
https://doi.org/10.3389/fphar.2022.808440
Journal volume & issue
Vol. 13

Abstract

Read online

Purpose: The purpose of the study is to evaluate the effects of 0.01% atropine eye drops on accommodative system parameters among teenagers with low myopia.Methods: Ninety-five myopic teenagers [39 boys (8.69 ± 2.473) and 56 girls (8.54 ± 2.054) aged 5–17 years] with no history of eye disease were enrolled. Biometric and accommodative system parameters were evaluated before and at 1 week, 1 month, 3 months, and 6 months of 0.01% atropine eye drop instillation.Results: Participants without accommodative demand at 6 months demonstrated insignificant changes after the atropine instillation (all p > 0.05). Nevertheless, there were significant differences in accommodative sensitivity, accommodative amplitude, accommodative responsiveness, and negative relative accommodation (NRA) at 3 months compared with baseline after atropine instillation (all p < 0.05). Except spherical equivalent refraction, cornea thickness, intraocular pressure, and axial length were stable after the 0.01% atropine instillation (all p > 0.05).Conclusion: Morphologically, current measurements suggested that 0.01% atropine had favorable reduction of accommodation for childhood low myopia over a half-year period.

Keywords